Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Vco Njar"'
Publikováno v:
Nigerian Journal of Natural Products and Medicine. 8
The chloroform soluble portion of methanolic extract of the root bark of Quassia undulata Simaroubaceae, gave four compounds: scopoletin 1, glaucarubinone 2, 15-desacetylundulatone 3 and a new coumarin, eniotorin 4. The structures were determined by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70c77b474d2934fdecb2bcfe299a9e46
https://doi.org/10.4314/njnpm.v8i1.11822
https://doi.org/10.4314/njnpm.v8i1.11822
Autor:
Dos Santos DZ; Princess Margaret Cancer Centre, University Health Network, 101 College Street, Toronto, ON M5G 1L7, Canada., Elbaz M; Princess Margaret Cancer Centre, University Health Network, 101 College Street, Toronto, ON M5G 1L7, Canada; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Helwan University, Ain Helwan, Helwan, Cairo, Egypt., Branchard E; Princess Margaret Cancer Centre, University Health Network, 101 College Street, Toronto, ON M5G 1L7, Canada., Schormann W; Biological Sciences, Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada., Brown CE; Krembil Research Institute, 60 Leonard Ave, Toronto, ON M5T 0S8, Canada., Meek AR; Krembil Research Institute, 60 Leonard Ave, Toronto, ON M5T 0S8, Canada., Njar VCO; Department of Pharmacology, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA., Hamilton RJ; Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Reed MA; Krembil Research Institute, 60 Leonard Ave, Toronto, ON M5T 0S8, Canada; Department of Pharmacology and Toxicology, Medical Sciences Building,1 King's College Circle, University of Toronto, M5S 1A8, Canada; Department of Chemistry, Lash Miller Building, 80 St. George Street, University of Toronto, Ontario M5S 3H6, Canada., Andrews DW; Biological Sciences, Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada; Department of Biochemistry, University of Toronto, 27 King's College Cir, Toronto, ON M5S 1A1, Canada; Department of Medical Biophysics, University of Toronto, 101 College Street, Toronto, ON M5G 1L7, Canada., Penn LZ; Princess Margaret Cancer Centre, University Health Network, 101 College Street, Toronto, ON M5G 1L7, Canada; Department of Medical Biophysics, University of Toronto, 101 College Street, Toronto, ON M5G 1L7, Canada. Electronic address: Linda.Penn@uhnresearch.ca.
Publikováno v:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2024 Aug; Vol. 177, pp. 116934. Date of Electronic Publication: 2024 Jun 17.
Autor:
Thankan RS; Department of Pharmacology, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA; Isoprene Pharmaceuticals, Inc. 801 West Baltimore Street, Suite 502J, Baltimore, MD 21201, USA. Electronic address: retheeshst@som.umaryland.edu., Thomas E; Department of Pharmacology, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA. Electronic address: elizabeththomas@som.umaryland.edu., Purushottamachar P; Department of Pharmacology, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA; Isoprene Pharmaceuticals, Inc. 801 West Baltimore Street, Suite 502J, Baltimore, MD 21201, USA. Electronic address: PPuranik@som.umaryland.edu., Weber DJ; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD 21201, USA; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA; Isoprene Pharmaceuticals, Inc. 801 West Baltimore Street, Suite 502J, Baltimore, MD 21201, USA. Electronic address: DWeber@som.umaryland.edu., Njar VCO; Department of Pharmacology, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA; Isoprene Pharmaceuticals, Inc. 801 West Baltimore Street, Suite 502J, Baltimore, MD 21201, USA. Electronic address: vnjar@som.umaryland.edu.
Publikováno v:
Bioorganic chemistry [Bioorg Chem] 2023 Oct; Vol. 139, pp. 106700. Date of Electronic Publication: 2023 Jun 25.
Autor:
Thankan RS; Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD, United States.; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, Baltimore, MD, United States.; Isoprene Pharmaceuticals, Inc., Baltimore, MD, United States., Thomas E; Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD, United States.; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, Baltimore, MD, United States., Purushottamachar P; Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD, United States.; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, Baltimore, MD, United States., Weber DJ; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, Baltimore, MD, United States.; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, United States.; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, United States., Ramamurthy VP; Isoprene Pharmaceuticals, Inc., Baltimore, MD, United States., Huang W; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD, United States., Kane MA; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD, United States., Njar VCO; Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD, United States.; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, Baltimore, MD, United States.; Isoprene Pharmaceuticals, Inc., Baltimore, MD, United States.; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, United States.
Publikováno v:
Frontiers in oncology [Front Oncol] 2023 Sep 11; Vol. 13, pp. 1240996. Date of Electronic Publication: 2023 Sep 11 (Print Publication: 2023).
Autor:
Thomas E; Department of Pharmacology, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA., Thankan RS; Department of Pharmacology, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA; Isoprene Pharmaceuticals, Inc., 801 W. Baltimore Street, Suite 502J, Baltimore, MD 21201, USA., Purushottamachar P; Department of Pharmacology, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA., Guo J; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA 15213, USA., Parise RA; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA 15213, USA., Beumer JH; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, PA 15213, USA; Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, PA 15261, USA; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. Electronic address: beumerjh@upmc.edu., Njar VCO; Department of Pharmacology, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA; Isoprene Pharmaceuticals, Inc., 801 W. Baltimore Street, Suite 502J, Baltimore, MD 21201, USA; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA. Electronic address: VNjar@som.umaryland.edu.
Publikováno v:
Steroids [Steroids] 2023 Apr; Vol. 192, pp. 109184. Date of Electronic Publication: 2023 Jan 24.
Autor:
Thomas E; Department of Pharmacology, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA.; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA., Thankan RS; Department of Pharmacology, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA.; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA.; Isoprene Pharmaceuticals, Inc., 801 W Baltimore Street, Suite 502J, Baltimore, MD 21201, USA., Purushottamachar P; Department of Pharmacology, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA.; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA., Weber DJ; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA.; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA., Njar VCO; Department of Pharmacology, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA.; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA.; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Feb 14; Vol. 15 (4). Date of Electronic Publication: 2023 Feb 14.
Autor:
Purushottamachar P; Department of Pharmacology, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA. Electronic address: PPuranik@som.umaryland.edu., Thomas E; Department of Pharmacology, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA., Thankan RS; Department of Pharmacology, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA; Flavocure Biotech, 701 E. Pratt Street, Suite 2033, Baltimore MD 21202, USA; Isoprene pharmaceuticals, Inc., 875 Hollins Street, Suite 102D, Baltimore, MD 21201, USA., Rudchenko V; Alchem Laboratories Corporation. 13305 Rachael Blvd., Alachua, FL 32615, USA., Huang G; Alchem Laboratories Corporation. 13305 Rachael Blvd., Alachua, FL 32615, USA., Njar VCO; Department of Pharmacology, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA; Isoprene pharmaceuticals, Inc., 875 Hollins Street, Suite 102D, Baltimore, MD 21201, USA; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA. Electronic address: VNjar@som.umaryland.edu.
Publikováno v:
Steroids [Steroids] 2022 Sep; Vol. 185, pp. 109062. Date of Electronic Publication: 2022 Jun 08.
Autor:
Thomas E; Department of Pharmacology, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA.; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA., Thankan RS; Department of Pharmacology, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA.; Flavocure Biotech, 701 E. Pratt St, Ste 2033, Baltimore, MD 21202, USA.; Isoprene Pharmaceuticals, Inc., 801 W Baltimore Street, Suite 502J, Baltimore, MD 21201, USA., Purushottamachar P; Department of Pharmacology, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA.; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA., Huang W; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA., Kane MA; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA., Zhang Y; Division of Biostatistics and Bioinformatics, University of Maryland, Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD 21201, USA.; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD 21201, USA., Ambulos NP; Department of Microbiology and Immunology, University of Maryland, Marlene Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD 21201, USA., Weber DJ; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA.; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA.; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD 21201, USA., Njar VCO; Department of Pharmacology, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA.; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA.; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA.
Publikováno v:
Cells [Cells] 2022 Aug 30; Vol. 11 (17). Date of Electronic Publication: 2022 Aug 30.
Autor:
Purushottamachar P; Department of Pharmacology, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD, 21201, USA; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD, 21201, USA. Electronic address: PPuranik@som.umaryland.edu., Thomas E; Department of Pharmacology, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD, 21201, USA; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD, 21201, USA., Thankan RS; Department of Pharmacology, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD, 21201, USA; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD, 21201, USA; Flavocure Biotech, 701 E. Pratt Street, Suite 2033, Baltimore, MD, 21202, USA; Isoprene Pharmaceuticals, Inc, 875 Hollins Street, Suite 102D, Baltimore, MD, 21201, USA., Njar VCO; Department of Pharmacology, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD, 21201, USA; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD, 21201, USA; Isoprene Pharmaceuticals, Inc, 875 Hollins Street, Suite 102D, Baltimore, MD, 21201, USA; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD, 21201, USA. Electronic address: VNjar@som.umaryland.edu.
Publikováno v:
European journal of medicinal chemistry [Eur J Med Chem] 2022 Aug 05; Vol. 238, pp. 114441. Date of Electronic Publication: 2022 May 14.
Autor:
Thomas E; Department of Pharmacology, University of Maryland School of Medicine, Baltimore, Maryland, USA.; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, Baltimore, Maryland, USA., Thankan RS; Department of Pharmacology, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Isoprene Pharmaceuticals Inc., Baltimore, Maryland, USA.; Flavocure Biotech, Baltimore, Maryland, USA., Purushottamachar P; Department of Pharmacology, University of Maryland School of Medicine, Baltimore, Maryland, USA.; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, Baltimore, Maryland, USA., Huang W; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland, USA., Kane MA; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland, USA., Zhang Y; Division of Biostatistics and Bioinformatics, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA.; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, USA., Ambulos N; Department of Microbiology and Immunology, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA., Weber DJ; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland, USA., Njar VCO; Department of Pharmacology, University of Maryland School of Medicine, Baltimore, Maryland, USA.; The Center for Biomolecular Therapeutics, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Publikováno v:
Molecular carcinogenesis [Mol Carcinog] 2022 Jul; Vol. 61 (7), pp. 643-654. Date of Electronic Publication: 2022 May 05.